Home » CORNERSTONE SIGNS CO-PROMOTION DEAL WITH ATHLON
CORNERSTONE SIGNS CO-PROMOTION DEAL WITH ATHLON
Cornerstone BioPharma on Monday announced a deal with an Alabama pharmaceutical firm to co-promote the Cary drug firm's pain medication Balacet. Financial details of the agreement were not disclosed.
Triangle Business Journal
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May